• Immunofluorescence analysis of SH-SY5Y cells using ADAMTS4 Rabbit polyclonal antibody (STJ22510) at dilution of 1:100 (40x lens). Secondary antibody: Cy3 Goat Anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.
  • Western blot analysis of lysates from Rat uterus using ADAMTS4 Rabbit polyclonal antibody (STJ22510) at 1:500 dilution. Secondary antibody:HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25  Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection:ECL Enhanced Kit. Exposuretime:120s.
  • Western blot analysis of lysates from Mouse heart using ADAMTS4 Rabbit polyclonal antibody (STJ22510) at 1:500 dilution. Secondary antibody:HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25  Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection:ECL Basic Kit. Exposuretime:3s.

Anti-ADAMTS4 antibody (74-318) (STJ22510)

SKU:
STJ22510

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB/IF
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-ADAMTS4 (74-318) is suitable for use in Western Blot and Immunofluorescence research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.05% Proclin300, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
IF/ICC 1:50-1:200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: ADAMTS4
Gene ID: 9507
Uniprot ID: ATS4_HUMAN
Immunogen Region: 74-318
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 74-318 of human ADAMTS4 (NP_005090.3).
Immunogen Sequence: GSGAPARLLCRLQAFGETLL LELEQDSGVQVEGLTVQYLG QAPELLGGAEPGTYLTGTIN GDPESVASLHWDGGALLGVL QYRGAELHLQPLEGGTPNSA GGPGAHILRRKSPASGQGPM CNVKAPLGSPSPRPRRAKRF ASLSRFVETLVVADDKMAAF HGAGLKRYLLTVMAAAAKAF KHPSIRNPVSLVVTRLVILG SGEEGPQVGPSAAQTLRSFC AWQRGLNTPEDSDPDHFDT
Tissue Specificity Expressed in brain, lung and heart. Expressed at very low level in placenta and skeletal muscles. Isoform 2: Detected in osteoarthritic synovium.
Post Translational Modifications The precursor is cleaved by a furin endopeptidase. Glycosylated. Can be O-fucosylated by POFUT2 on a serine or a threonine residue found within the consensus sequence C1-X(2)-(S/T)-C2-G of the TSP type-1 repeat domains where C1 and C2 are the first and second cysteine residue of the repeat, respectively. Fucosylated repeats can then be further glycosylated by the addition of a beta-1,3-glucose residue by the glucosyltransferase, B3GALTL. Fucosylation mediates the efficient secretion of ADAMTS family members. Can also be C-glycosylated with one or two mannose molecules on tryptophan residues within the consensus sequence W-X-X-W of the TPRs, and N-glycosylated. These other glycosylations can also facilitate secretion.
Function Cleaves aggrecan, a cartilage proteoglycan, and may be involved in its turnover. May play an important role in the destruction of aggrecan in arthritic diseases. Could also be a critical factor in the exacerbation of neurodegeneration in Alzheimer disease. Cleaves aggrecan at the '392-Glu-|-Ala-393' site.
Protein Name A Disintegrin And Metalloproteinase With Thrombospondin Motifs 4
Adam-Ts 4
Adam-Ts4
Adamts-4
Admp-1
Aggrecanase-1
Database Links Reactome: R-HSA-1474228
Reactome: R-HSA-5083635
Reactome: R-HSA-5173214
Cellular Localisation Secreted
Extracellular Space
Extracellular Matrix
Alternative Antibody Names Anti-A Disintegrin And Metalloproteinase With Thrombospondin Motifs 4 antibody
Anti-Adam-Ts 4 antibody
Anti-Adam-Ts4 antibody
Anti-Adamts-4 antibody
Anti-Admp-1 antibody
Anti-Aggrecanase-1 antibody
Anti-ADAMTS4 antibody
Anti-KIAA0688 antibody
Anti-UNQ769 antibody
Anti-PRO1563 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance